Sou Hu Cai Jing·2025-05-08 07:29Summary of Key Points Core Viewpoint - The report highlights the trends in the annual compensation of chairpersons of A-share listed companies, indicating a decline in the number of chairpersons earning over 10 million yuan, particularly in the context of performance-related pay adjustments across various industries [1][4]. Group 1: Compensation Overview - A total of 4,231 listed companies disclosed their chairpersons' annual compensation, amounting to 5.789 billion yuan [1]. - Thirteen chairpersons earned over 10 million yuan, primarily from the biopharmaceutical, electronics, home appliances, food and beverage, media, and basic chemicals sectors [1]. - The top three earners were from the biopharmaceutical industry: WuXi AppTec's chairperson earned 41.8 million yuan, Mindray Medical's chairperson earned 24.939 million yuan, and BeiGene's chairperson earned 20.194 million yuan [2]. Group 2: Trends in High Compensation - The number of chairpersons with annual salaries exceeding 10 million yuan has decreased from 27 in 2022 to 16 in 2023, and further down to 13 in 2024 [4]. - The distribution of chairpersons' salaries shows a concentration in the 1 million to 2 million yuan range, with 1,402 individuals (one-third of the total) falling within this bracket [3]. Group 3: Salary Adjustments and Performance Impact - Many companies announced salary reductions for executives in 2024, with notable examples including Minglida's chairperson voluntarily waiving half of their salary and Haineng's management team experiencing significant pay cuts [5]. - A total of 3,765 chairpersons had comparable salaries from 2023 to 2024, with 1,377 (37%) experiencing a decrease, while 1,985 (58%) saw an increase [5]. - The primary reason for voluntary salary reductions among high-earning chairpersons was a decline in company performance, as illustrated by the significant pay cuts at Longi Green Energy and Meihua Biological, where chairpersons faced reductions of 92.24% and 83.61%, respectively [6].